Photodynamic therapy of eye diseases

Ophthalmic Surgery and Lasers

Volumn 30, Issue 8, 1999, Pages 653-661

  Rivellese, Mark J ^a   Baumal, Caroline R ^a,b  

^a NEW ENGLAND EYE CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCHLORIN; BENZOPORPHYRIN DERIVATIVE; CHLOROALUMINUM PHTHALOCYANINE; ETIOPURPURIN; HEMATOPORPHYRIN DERIVATIVE; HYDROGEN; LIPOPROTEIN; LIPOSOME; LOW DENSITY LIPOPROTEIN RECEPTOR; LUTETIUM; PHOTOFRIN; PHOTOFRIN II; PROGESTERONE; PURPURIN; SILICON DERIVATIVE; SINGLET OXYGEN; SUPEROXIDE; UNCLASSIFIED DRUG;

CILIARY BODY; CLINICAL TRIAL; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LASER COAGULATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SKIN DISEASE; SKIN SENSITIVITY; SUBRETINAL NEOVASCULARIZATION; UVEA MELANOMA;

EID: 0032871436     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Raab O. Uber die wirkung fluoreszierenden stoffen. Infusuria Zeitschrift Biologic. 1900;524-546.
2. Liu H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin. 1993; 11:1-13.
3. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy II: cure of animal tumors with hematoporphyrin and light. J Nat Cancer Inst. 1975;55:115-121.
4. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer. 1992;28A:1734-1742.
5. Foote CS. Mechanisms of photooxidation. In: Dorion DR, Gomer CJ, eds. Porphyrin Localization and Treatment of Tumors. New York, NY: Alan R Liss; 1984:3-18.
6. Buettner GR, Oberly LW. The apparent production of superoxide and hydroxyl radicals by hematoporphyrin and light as seen by spin-trapping. FEES Lett. 1980;121:161-164.
7. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 1976;36:2326-2329.
8. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2-31.
9. Gomer CJ, Rucker N. Ferrario A, Wong S. Properties and applications of photodynamic therapy. Radiation Research. 1989;120:1-18.
10. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
11. Roberts WG, Hasan T. Role of neovasculature and vascular permiability on the tumor retention of photodynamic agents. Cancer Res. 1992;52:924-930.
12. Jori G, Reddi E. The role of lipoproteins in the delivery of tumour-targeting photosensitizers. Int J Biochem Cell Biol. 1993;25:1369-1372.
13. Husain D, Miller JW, Michaud N, et al. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996;114:978-985.
14. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 1996;103:427-438.
15. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of expert mental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995;113:810-818.
16. Schmidt-Erfurth U, Hasan T, Flotte T, Gragoudas E, Birngruber R. Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein. Ophthalmology. 1994;91:348-356.
17. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology. 1994;101:89-99.
18. Dougherty TJ, Potter WR, Weishaupt KR. The structure of the active component of hematoporphyrin derivative. In: Dorion DR, Gomer CJ, eds. Porphyrin Localization and Treatment of Tumors. New York, NY: Alan R Liss; 1984;301-314.
19. Kim RY, Hu LK, Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas of greater than 3 mm thickness. Ophthalmology. 1996;103:2029-2036.
20. Richter AM, Cerruti-Sola S, Sternberg ED. Biodistribution of titrated benzoporphyrin derivative (H-BPD-MA), a new potent photosensitizer in normal and tumor bearing mice. J Photochem Photobiol. 1990;5:231-234.
21. Kreimer-Birnbaum M. Modified porphyrins, chlorine, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Semin Hematol. 1989;26:157-173.
22. Richter AM, Kelly B, Chow J. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Nat Cancer Inst. 1987;79:1327-1332.
23. Razum NJ, Snyder AB, Doiron DR. SnET2: clinical update. SPIE Proceedings. Optical Methods for Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy. 1996;2675:43-46.
24. Blumenkranz MS, Woodburn K, Verdooner S. Lutetium texaphyrin angiography: a new method for the evaluation and treatment of retinal and choroidal vascular disorders [abstract]. Invest Ophthal Vis Sci. 1998;39:S468.
25. Krohn SL, Brandt R, Morris DA, Keston AS. Subchoroidal transplantation of an experimental malignant melanoma. Am J Ophthalmol. 1970;70:573-618.
26. Ozler SA, Nelson JS, Liggett PE, de Queiroz JM, Jr., Berns MW. Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol. 1992;110:555-561.
27. Gonzalez VH, Hu LK, Theodossiadis PG, et al. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthal Vis Sci. 1995;36:871-878.
28. Young LH, Howard MA, Hu LK, Kim RY, Gragoudas ES. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol. 1996;114:186-192.
29. Panagopoulos JA, Svitra PP, Puliafito CA, Gragoudas ES. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol. 1989;107:886-890.
30. Schuitmaker JJ, van Best JA, van Delft JL, et al. Bacteriochlorin a, a new photosensitizer in photodynamic therapy: in vivo results. Invest Ophthal Vis Sci. 1990;31:1444-1450.
31. Schuitmaker JJ, Vrensen GF, van Delft JL, et al. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Invest Ophthal Vis Sci. 1991;32:2683-2688.
32. Liu LHS, Ni C. Hematoporphyrin phototherapy for experimental intraocular malignant melanoma. Arch Ophthalmol. 1983;101:901-903.
33. Hu LK, Huh K, Gragoudas ES, Young LHY. Establishment of pigmented choroidal melanomas in a rabbit model. Retina. 1994;14:264-269.
34. Tse DT, Dutton JJ, Weingeist TA, Hermsen VM, Kersten RC. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol. 1984;102:833-838.
35. Sery TW, Shields JA, Augsburger JJ, Shah HG. Photodynamic therapy of human ocular cancer. Ophthalmic Surg. 1987;18:413-418.
36. Davidorf J, Davidorf F. Treatment of iris melanoma with photodynamic therapy. Ophthalmic Surg. 1992;23:522-527.
37. Bruce RA, Jr. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas. Lasers Surg Med. 1984;4:59-64.
38. Bruce RA, Jr. Photoradiation of choroidal malignant melanoma. Progress in Clinical & Biological Research. 1984;170:777-784.
39. Favilla I, Favilla ML, Gosbell AD, et al. Photodynamic therapy: a 5-year study of its effectiveness in the treat-ment of posterior uveal melanoma, and evaluation of Hematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture. Melanoma Research. 1995;5:355-364.
40. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol. 1987;46:919-923.
41. Tse DT. Laser photocoagulation of choroidal malignant melanoma. Biomedicine & Pharmacotherapy. 1986;40:323-325.
42. Ohnishi Y, Yamana Y, Minei M. Photoradiation therapy using argon laser and a hematoporphyrin derivative for retinoblastoma: a preliminary report. Jpn J Ophthalmol. 1986;30:409-419.
43. Manyak MJ, Russo A, Smith PD, Glatstein E. Photodynamic therapy. Journal of Clinical Oncology. 1988;6:380-391.
44. Pooler JP, Valenzeno DP. Dye-sensitized photodynamic inactivation of cells. Medical Physics. 1981;8:614-628.
45. Virdi PS, Hayreh SS. Ocular neovascularization with retinal vascular occlusion. Arch Ophthalmol. 1982;100:331-341.
46. Miller JW, Stinson WG, Gregory WA, el-Koumy HA, Puliafito CA. Phthalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology. 1991;98:1711-1719.
47. Husain D, Miller JW, Kenney AG, et al. Photodynamic therapy and digital angiography of experimental neovascularization using liposomal benzoporphyrin derivative. Ophthalmology. 1997;104:1242-1250.
48. Nanda SK, Hatchell DL, Tiedeman JS. A new method for vascular occlusion. Arch Ophthalmol. 1987;105: 1121-1124.
49. Iliaki OK, Naoumidi II, Tsilimbaris MK, Pallikaris IG. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser. Lasers Surg Med. 1996;19:311-323.
50. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med. 1994;15:2-10.
51. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res. 1994;13:513-522.
52. Peyman GA, Moshfeghi DM, Moshfeghi A, et al. Photodynamic therapy of choriocapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic Surg Lasers. 1997;28:409-417.
53. Servais GE, Dreyer RF, Folk JC, Tse DT. Obliteration of choroidal and retinal vessels with HPD photoradiation. Invest Ophthal Vis Sci. 1985;26:210.
54. Schmidt-Erfurth U, Hasan T, Gragoudas E, Birngruber R. Selective occlusion of subretinal neovascularization with photodynamic therapy. Ophthalmology. 1994;91:789-795.
55. Kliman GH, Stern D, Gregory WA, Borirak, S, Puliafito CA. Angiography and photodynamic therapy of experimental choroidal neovascularization using phthalocyanine dye. Invest Ophthal Vis Sci. 1989;30(suppl):371.
56. Baumal CR, Puliafito CA, Pieroth L, et al. Photodynamic therapy of experimental choroidal neovascularization with tin ethyl etiopurpurin [abstract]. Invest Ophthalmol Vis Sci. 1996;37(suppl):S122.
57. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998;236:365-374.
58. Corner CJ, Doiron DR, White L, et al. Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res. 1984;3:229-237.
59. Hill RA, Garrett J, Reddi S, et al. Photodynamic therapy (PDT) of the ciliary body with silicon naphthalocyanine (SINc) in rabbits. Lasers Surg Med. 1996;18:86-91.
60. Hill RA, Crean DH, Dorion DR, et al. Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits. Ophthalmic Surg Lasers. 1997;28:948-953.